Choong Ang Vaccine Laboratory Co., Ltd. (KOSDAQ: 072020)
South Korea
· Delayed Price · Currency is KRW
9,980.00
+150.00 (1.53%)
Dec 19, 2024, 9:00 AM KST
Choong Ang Vaccine Laboratory Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2012 | FY 2011 | 2010 - 2006 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '12 Dec 31, 2012 | Dec '11 Dec 31, 2011 | 2010 - 2006 |
Net Income | 3,649 | 4,044 | 7,602 | 3,164 | 4,372 | 2,368 | Upgrade
|
Depreciation & Amortization | 6,016 | 6,054 | 5,006 | 4,390 | - | - | Upgrade
|
Loss (Gain) From Sale of Assets | -0.14 | -0.72 | -842.11 | 850.29 | - | - | Upgrade
|
Asset Writedown & Restructuring Costs | - | - | - | 110.49 | - | - | Upgrade
|
Loss (Gain) From Sale of Investments | 32.95 | 92.18 | -50.51 | -72.22 | - | - | Upgrade
|
Loss (Gain) on Equity Investments | 1.79 | 1.91 | 4.29 | - | - | - | Upgrade
|
Provision & Write-off of Bad Debts | 552.51 | 535.67 | 16.25 | 6.41 | - | - | Upgrade
|
Other Operating Activities | 904.11 | 620.61 | -339.83 | 643.79 | 787.56 | 2,569 | Upgrade
|
Change in Accounts Receivable | -755.39 | -459.91 | -1,161 | 40.85 | - | - | Upgrade
|
Change in Inventory | -3,034 | -3,260 | 1,118 | -444.43 | - | - | Upgrade
|
Change in Accounts Payable | -300.65 | -163.93 | 164.8 | -83.83 | - | - | Upgrade
|
Change in Other Net Operating Assets | -659.34 | -378.81 | 8.57 | -289.17 | - | - | Upgrade
|
Operating Cash Flow | 6,406 | 7,086 | 11,525 | 8,316 | 5,159 | 4,936 | Upgrade
|
Operating Cash Flow Growth | -36.00% | -38.52% | 38.60% | 61.18% | 4.52% | - | Upgrade
|
Capital Expenditures | -5,019 | -7,104 | -14,311 | -15,404 | -12,428 | -1,757 | Upgrade
|
Sale of Property, Plant & Equipment | 28 | 28.58 | 2,779 | 9.66 | 0.31 | 7.73 | Upgrade
|
Sale (Purchase) of Intangibles | -66 | -66 | -55 | - | -721.69 | -395.76 | Upgrade
|
Investment in Securities | 4,545 | -503.76 | -201.54 | 2,247 | 5,312 | -2,313 | Upgrade
|
Other Investing Activities | -1,556 | -1,536 | -211.15 | 0 | - | - | Upgrade
|
Investing Cash Flow | -2,069 | -9,181 | -12,000 | -13,148 | -7,837 | -4,457 | Upgrade
|
Short-Term Debt Issued | - | - | - | - | 2,500 | - | Upgrade
|
Long-Term Debt Issued | - | 6,000 | 7,000 | 6,000 | - | - | Upgrade
|
Total Debt Issued | 4,000 | 6,000 | 7,000 | 6,000 | 2,500 | - | Upgrade
|
Long-Term Debt Repaid | - | -5,584 | -5,599 | -187.91 | - | - | Upgrade
|
Total Debt Repaid | -4,587 | -5,584 | -5,599 | -187.91 | - | - | Upgrade
|
Net Debt Issued (Repaid) | -586.87 | 416.49 | 1,401 | 5,812 | 2,500 | - | Upgrade
|
Repurchase of Common Stock | -1,122 | -1,041 | -1,587 | -1,385 | - | - | Upgrade
|
Common Dividends Paid | - | - | - | - | -366 | -366 | Upgrade
|
Dividends Paid | -975.87 | -975.87 | -690.11 | -497.93 | -366 | -366 | Upgrade
|
Other Financing Activities | - | - | - | 0 | 898 | 178.68 | Upgrade
|
Financing Cash Flow | -2,685 | -1,600 | -876.9 | 3,929 | 3,032 | -187.32 | Upgrade
|
Foreign Exchange Rate Adjustments | 230.25 | 206.95 | 407.05 | -213.12 | -54.77 | 3.25 | Upgrade
|
Miscellaneous Cash Flow Adjustments | 0 | 0 | 0 | -0 | - | - | Upgrade
|
Net Cash Flow | 1,883 | -3,489 | -944.28 | -1,116 | 299.09 | 294.76 | Upgrade
|
Free Cash Flow | 1,387 | -17.84 | -2,785 | -7,088 | -7,269 | 3,180 | Upgrade
|
Free Cash Flow Margin | 3.54% | -0.05% | -6.81% | -19.52% | -37.73% | 20.40% | Upgrade
|
Free Cash Flow Per Share | 142.62 | -1.83 | -282.96 | -717.49 | -827.17 | 361.49 | Upgrade
|
Cash Interest Paid | 264.88 | 236.42 | 105.27 | 91.11 | 31.56 | 12.64 | Upgrade
|
Cash Income Tax Paid | 395.04 | 393.25 | -319.64 | 453.2 | 565.3 | 200.2 | Upgrade
|
Levered Free Cash Flow | -503.45 | -2,887 | -4,504 | - | -4,599 | - | Upgrade
|
Unlevered Free Cash Flow | -333.71 | -2,735 | -4,436 | - | -4,599 | - | Upgrade
|
Change in Net Working Capital | 3,758 | 4,296 | -2,086 | - | -5,787 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.